With Covid-19 cases on the rise in India once again and the nationwide immunisation drive against the SARS-CoV-2 virus aiming to cover 300 million people by August, the government has increased its demand for Covishield and Covaxin — the two vaccines currently in use here.

Leave a Reply

Your email address will not be published. Required fields are marked *